Clinical investigation of combination therapy with a1 blocker and vibegron for treating overactive bladder in patients with benign prostatic hyperplasia
Not Applicable
Recruiting
- Conditions
- overactive bladder
- Registration Number
- JPRN-UMIN000039150
- Lead Sponsor
- Koto Hospital, Dept. of Urology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Suspect of malignancy 2) Patient with allergy to beta 3 agonists 3) Patient using a1 blocker within 4 weeks 4) Patients whom investigators consider to be ineligible.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method